229 related articles for article (PubMed ID: 17051566)
41. The role of liver transplantation for hilar cholangiocarcinoma.
Pandey D; Lee KH; Tan KC
Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):248-53. PubMed ID: 17548246
[TBL] [Abstract][Full Text] [Related]
42. Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma: a single-center experience.
Sotiropoulos GC; Kaiser GM; Lang H; Molmenti EP; Beckebaum S; Fouzas I; Sgourakis G; Radtke A; Bockhorn M; Nadalin S; Treckmann J; Niebel W; Baba HA; Broelsch CE; Paul A
Transplant Proc; 2008 Nov; 40(9):3194-5. PubMed ID: 19010231
[TBL] [Abstract][Full Text] [Related]
43. Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma.
Jiang BG; Sun LL; Yu WL; Tang ZH; Zong M; Zhang YJ
Cancer J; 2009; 15(3):257-61. PubMed ID: 19556914
[TBL] [Abstract][Full Text] [Related]
44. Pretransplant psychiatric and substance use comorbidity in patients with cholangiocarcinoma who received a liver transplant.
Schneekloth TD; Jowsey SG; Biernacka JM; Burton MC; Vasquez AR; Bergquist T; Drews MS; Gores GJ
Psychosomatics; 2012; 53(2):116-22. PubMed ID: 22424159
[TBL] [Abstract][Full Text] [Related]
45. Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma.
Yamamoto M; Ariizumi S
J Gastroenterol; 2006 Sep; 41(9):925-6. PubMed ID: 17048061
[No Abstract] [Full Text] [Related]
46. Recent advance in the treatment of hilar cholangiocarcinoma: hepatectomy with vascular resection.
Miyazaki M; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I
J Hepatobiliary Pancreat Surg; 2007; 14(5):463-8. PubMed ID: 17909714
[TBL] [Abstract][Full Text] [Related]
47. Management of combined hepatocellular and cholangiocarcinoma.
Kassahun WT; Hauss J
Int J Clin Pract; 2008 Aug; 62(8):1271-8. PubMed ID: 18284443
[TBL] [Abstract][Full Text] [Related]
48. Cholangiocarcinoma, 10-Year Survival After Liver Transplantation: A Case Report.
Herrero Torres MA; Dominguez Bastante M; Molina Raya A; Palomo Lopez I; Santoyo Villalba J; Villegas Herrera MT; Becerra Massare A; Brea Gomez E; Zambudio Carroll N; Villar Del Moral JM
Transplant Proc; 2020 Mar; 52(2):592-593. PubMed ID: 32057500
[TBL] [Abstract][Full Text] [Related]
49. [Prolonged survival following limited surgery in cholangiocarcinoma].
Echenique Elizondo M
Gastroenterol Hepatol; 2000 Jan; 23(1):24. PubMed ID: 10726380
[No Abstract] [Full Text] [Related]
50. Intrahepatic cholangiocarcinoma: a worthy challenge.
Bartlett DL
Cancer J; 2009; 15(3):255-6. PubMed ID: 19556913
[No Abstract] [Full Text] [Related]
51. [Experience of surgical resection of 103 hilar cholangiocarcinoma].
Liang LJ; Lai JM; Li SQ; Peng BG; Yin XY; Tang D; Lü MD; Huang JF
Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):882-4. PubMed ID: 17067476
[TBL] [Abstract][Full Text] [Related]
52. Multivisceral cluster transplantation: a preliminary experience.
Petrassi A; Rossi M; Venettoni S; Alfani D; Roncone A; Cortesini R
Chir Ital; 1999; 51(1):79-86. PubMed ID: 10514921
[No Abstract] [Full Text] [Related]
53. Increasing incidence of cholangiocarcinoma in Crete 1992-2000.
Mouzas IA; Dimoulios P; Vlachonikolis IG; Skordilis P; Zoras O; Kouroumalis E
Anticancer Res; 2002; 22(6B):3637-41. PubMed ID: 12552969
[TBL] [Abstract][Full Text] [Related]
54. Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy.
Nanashima A; Sumida Y; Abo T; Nagasaki T; Takeshita H; Fukuoka H; Sawai T; Tanaka K; Yasutake T; Nagayasu T
Hepatogastroenterology; 2007 Dec; 54(80):2337-42. PubMed ID: 18265660
[TBL] [Abstract][Full Text] [Related]
55. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
Demols A; Maréchal R; Devière J; Van Laethem JL
Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
[TBL] [Abstract][Full Text] [Related]
56. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
[TBL] [Abstract][Full Text] [Related]
57. [Surgery for hilar cholangiocarcinoma--result and limit of surgical treatment].
Nimura Y
Nihon Shokakibyo Gakkai Zasshi; 2001 Mar; 98(3):269-77. PubMed ID: 11280903
[No Abstract] [Full Text] [Related]
58. The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma.
Shimizu Y; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Miyazaki M
Hepatogastroenterology; 2008; 55(82-83):699-703. PubMed ID: 18613437
[TBL] [Abstract][Full Text] [Related]
59. [Diagnostics and treatment of cholangiocarcinoma].
Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
[TBL] [Abstract][Full Text] [Related]
60. Extrahepatic cholangiocarcinoma: current surgical strategy.
Boutros C; Somasundar P; Espat NJ
Surg Oncol Clin N Am; 2009 Apr; 18(2):269-88, viii. PubMed ID: 19306812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
